Answers are grounded in this paper and cite their sources.
Astatine-211 (²¹¹At) has physical properties that make it one of the top candidates for use as a radiation source for alpha particle-based radionuclide therapy, also referred to as targeted alpha therapy (TAT). Here, we summarize the main results of the completed clinical trials, further describe ongoing trials, and discuss future prospects.
No takes yet. Share an insight, caveat, or question.
Albertsson et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: